ANN ARBOR, MI--(Marketwire - May 15, 2008) - Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of neurologic and autoimmune diseases, today announced its clinical update and results for its first quarter of 2008.
